European Commission 31 March 2017, Commission Regulation (EU) 2017/626 of 31 March 2017 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, cyantraniliprole, cypermethrin, cyprodinil, difenoconazole, ethephon, fluopyram, flutriafol, fluxapyroxad, imazapic, imazapyr, lambda-cyhalothrin, mesotrione, profenofos, propiconazole, pyrimethanil, spirotetramat, tebuconazole, triazophos and trifloxystrobin in or on certain products (Text with EEA relevance. )
Also known as
European Union · · · Cited by 49 · 31-03-2017
7.4.2017
EN
Official Journal of the European Union
L 96/1
COMMISSION REGULATION (EU) 2017/626
of 31 March 2017
amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, cyantraniliprole, cypermethrin, cyprodinil, difenoconazole, ethephon, fluopyram, flutriafol, fluxapyroxad,
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (49 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit